Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

Uflex

₹428.7 6.3 | 1.5%

Market Cap ₹3096 Cr.

Stock P/E -7.4

P/B 0.4

Current Price ₹428.7

Book Value ₹ 990.6

Face Value 10

52W High ₹499.9

Dividend Yield 0.7%

52W Low ₹ 371

Uflex Research see more...

Overview Inc. Year: 1988Industry: Packaging

UFLEX Ltd is a holding company, that is engaged inside the production and sale of flexible packaging merchandise. The Company's segments consist of Flexible Packaging Activities and Engineering Activities. It also gives a flexible packaging option to its customers across the globe. Its business includes aseptic liquid packaging, bendy packaging, packaging films, chemical's business, cylinder enterprise, engineering business and holography enterprise. It is also engaged in production of purchaser facing products like N-95 masks and sanitizers. It manufactures a whole lot of flexible packaging films, which include biaxially oriented polypropylene (BOPP) films, biaxially oriented polyethylene terephthalate (BOPET) films, cast unoriented polypropylene (CPP) film, metalized films, alox lined films and post-purchaser recycled content material (PCR) grade polyethylene terephthalate (PET) movies asclepius. It offers finished packaging to various merchandise, together with snack ingredients, candy and confectionery.

Read More..

Uflex Share Price

New

| |

Volume
Price

Quarterly Price

Show Value Show %

Peer Comparison

Uflex Quarterly Results

#(Fig in Cr.) Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 3027 3444 3868 4032 3768 3483 3380 3258 3369 3309
Other Income 8 30 85 13 81 16 19 22 20 42
Total Income 3036 3474 3953 4045 3849 3498 3399 3280 3389 3351
Total Expenditure 2612 2856 3219 3321 3356 3219 3011 2975 2984 2978
Operating Profit 424 618 734 724 493 279 389 306 406 373
Interest 75 86 98 105 105 133 130 135 132 140
Depreciation 135 135 140 144 146 144 166 161 164 166
Exceptional Income / Expenses 0 0 -38 0 0 -84 -66 -382 0 -100
Profit Before Tax 214 397 458 475 242 -81 28 -371 110 -33
Provision for Tax 44 84 107 101 51 2 21 43 46 28
Profit After Tax 170 313 351 374 191 -83 7 -414 63 -62
Adjustments 0 0 -0 1 -0 -2 -6 -2 0 -6
Profit After Adjustments 171 313 350 374 191 -85 1 -416 63 -67
Adjusted Earnings Per Share 23.6 43.4 48.5 51.9 26.4 -11.8 0.1 -57.6 8.8 -9.3

Uflex Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 5161 5863 6180 6035 6157 6709 7957 7405 8889 13127 14663 13316
Other Income 31 29 29 52 33 23 21 29 33 122 165 103
Total Income 5192 5892 6209 6087 6190 6732 7978 7434 8922 13249 14827 13419
Total Expenditure 4520 5180 5449 5242 5295 5833 6968 6323 7097 10970 12941 11948
Operating Profit 672 712 760 845 895 899 1011 1111 1826 2279 1886 1474
Interest 230 233 199 181 187 197 218 225 229 322 473 537
Depreciation 236 267 279 286 318 352 381 403 456 537 599 657
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 -38 -150 -548
Profit Before Tax 209 217 286 382 395 354 409 481 1142 1382 656 -266
Provision for Tax 19 15 31 65 44 42 94 110 299 283 175 138
Profit After Tax 190 202 255 317 351 312 315 371 844 1099 481 -406
Adjustments 0 0 -1 -3 -2 -2 -1 -1 -1 -1 -0 -14
Profit After Adjustments 190 202 255 314 348 310 314 370 843 1098 481 -419
Adjusted Earnings Per Share 26.4 27.9 35.3 43.5 48.3 43 43.5 51.2 116.7 152.1 66.6 -58

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 12% 26% 17% 11%
Operating Profit CAGR -17% 19% 16% 11%
PAT CAGR -56% 9% 9% 10%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 0% -1% 14% 18%
ROE Average 7% 14% 11% 10%
ROCE Average 9% 14% 12% 11%

Uflex Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 2499 2823 3008 3448 3629 3975 4298 4690 5549 6687 7496
Minority's Interest 0 0 1 4 15 5 6 7 8 9 9
Borrowings 1301 1329 1006 1054 1030 1055 876 2451 2807 3072 3463
Other Non-Current Liabilities 184 154 134 165 154 158 215 260 438 596 621
Total Current Liabilities 1980 2289 2319 2133 2321 2496 2564 2608 3019 4078 4847
Total Liabilities 5964 6595 6468 6804 7148 7688 7960 10016 11820 14441 16438
Fixed Assets 3339 3378 3240 3255 3360 3750 3744 3794 5020 6406 7774
Other Non-Current Assets 271 372 334 632 785 452 661 2548 2071 1348 1094
Total Current Assets 2354 2845 2894 2917 3003 3487 3554 3674 4729 6687 7569
Total Assets 5964 6595 6468 6804 7148 7688 7960 10016 11820 14441 16438

Uflex Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 168 162 207 192 388 296 316 288 402 616 588
Cash Flow from Operating Activities 541 331 501 875 779 651 553 849 1174 709 1383
Cash Flow from Investing Activities -531 -143 -197 -437 -669 -427 -344 -2062 -1095 -952 -1172
Cash Flow from Financing Activities -17 -143 -319 -242 -202 -205 -237 1369 134 216 292
Net Cash Inflow / Outflow -6 45 -15 196 -92 19 -27 155 214 -28 503
Closing Cash & Cash Equivalent 162 207 192 388 296 316 288 444 616 588 1091

Uflex Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 26.36 27.92 35.28 43.46 48.25 43 43.46 51.21 116.73 152.09 66.57
CEPS(Rs) 59.04 64.91 74.07 83.43 92.55 91.92 96.39 107.19 179.94 226.63 149.53
DPS(Rs) 2.4 2.5 2.7 3.2 3.5 2 2 2 2.5 3 3
Book NAV/Share(Rs) 346.01 390.92 416.51 477.46 502.53 550.43 595.2 649.45 768.37 925.97 1038.08
Core EBITDA Margin(%) 11.04 10.47 10.64 11.75 12.12 12.03 11.8 13.83 19.2 15.87 11.43
EBIT Margin(%) 7.56 6.89 7.06 8.35 8.18 7.56 7.47 9.02 14.69 12.54 7.5
Pre Tax Margin(%) 3.6 3.32 4.16 5.66 5.55 4.86 4.87 6.15 12.24 10.17 4.36
PAT Margin (%) 3.28 3.09 3.72 4.7 4.93 4.29 3.76 4.74 9.04 8.09 3.19
Cash Profit Margin (%) 7.34 7.18 7.78 8.93 9.4 9.11 8.3 9.9 13.92 12.04 7.17
ROA(%) 3.38 3.21 3.91 4.78 5.03 4.21 4.03 4.13 7.73 8.37 3.11
ROE(%) 8.12 7.58 8.76 9.82 9.91 8.21 7.62 8.25 16.48 17.97 6.78
ROCE(%) 9.81 9.01 9.28 10.42 10.27 9.35 10.06 9.61 15.4 16.41 9.32
Receivable days 71.39 77.76 79.99 80.88 80.58 89.99 86.58 93.18 85.02 79.37 81.69
Inventory Days 28.41 30.22 33.75 34.68 33.36 36.97 35.7 39.64 39.21 40.03 50.18
Payable days 74.6 78.8 77.73 79.3 89.32 96.87 84.28 90.42 93.04 77.49 81.24
PER(x) 2.74 2.55 3.31 4.01 5.76 7.9 5.23 2.69 3.24 4 5.04
Price/Book(x) 0.21 0.18 0.28 0.36 0.55 0.62 0.38 0.21 0.49 0.66 0.32
Dividend Yield(%) 3.32 3.51 2.31 1.84 1.26 0.59 0.88 1.45 0.66 0.49 0.89
EV/Net Sales(x) 0.51 0.46 0.46 0.5 0.62 0.63 0.43 0.56 0.69 0.64 0.47
EV/Core EBITDA(x) 3.88 3.82 3.77 3.56 4.26 4.69 3.42 3.73 3.34 3.67 3.62
Net Sales Growth(%) 14.29 13.61 5.41 -2.36 2.02 8.96 18.61 -6.94 20.04 47.68 11.7
EBIT Growth(%) -12.92 2.53 7.82 16.06 3.22 -5.22 13.74 12.6 94.33 24.32 -33.75
PAT Growth(%) -25.2 5.91 26.72 24.05 10.67 -10.99 0.96 17.66 127.48 30.31 -56.27
EPS Growth(%) -25.35 5.92 26.34 23.19 11.03 -10.9 1.08 17.84 127.92 30.3 -56.23
Debt/Equity(x) 0.9 0.86 0.73 0.62 0.58 0.52 0.49 0.77 0.72 0.68 0.73
Current Ratio(x) 1.19 1.24 1.25 1.37 1.29 1.4 1.39 1.41 1.57 1.64 1.56
Quick Ratio(x) 0.95 0.98 0.96 1.08 1 1.08 1.06 1.08 1.19 1.2 1.09
Interest Cover(x) 1.91 1.93 2.44 3.1 3.11 2.8 2.88 3.14 5.99 5.29 2.39
Total Debt/Mcap(x) 4.31 4.7 2.62 1.7 1.05 0.85 1.28 3.6 1.46 1.04 2.27

Uflex Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 44.02 44.02 44.58 44.58 44.58 44.58 44.58 44.58 44.58 44.58
FII 6.42 6.66 7.09 8.65 8.31 7.22 7.11 6.48 7.01 7.44
DII 1.08 0.32 0.18 0.25 0.28 0.68 0.69 0.7 0.72 0.73
Public 48.48 49 48.15 46.52 46.83 47.51 47.63 48.24 47.69 47.25
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Stock is trading at 0.4 times its book value

Cons

  • Promoter holding is low: 44.58%.
  • Company has a low return on equity of 14% over the last 3 years.
  • Debtor days have increased from 77.49 to 81.24days.
  • The company has delivered a poor profit growth of 9% over past five years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Uflex News

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....